Site under construction

Sudden cardiac deaths (SCD), also known as sudden cardiac arrest, accounts for 10-15% of all deaths in adults (320 000-400 000 deaths each year in Europe) equivalent to the cumulative mortality of lung and breast cancers. The paradox is that efficient treatment options exist, such as implantable defibrillators. The major unsolved problem remains in how to non-invasively identify subjects at risk prior to death.

Pulsheart was founded in 2023 By Prof. Michel Haïssaguerre and colleagues from the Liryc research center (159 international multidisciplinary experts in cardiology) to develop and validate software and hardware to tackle this major screening need, assess early a potential risk and prevent SCD.